“I will invest where I believe my products are going to be used,” said Soriot in a call with reporters on Thursday, responding to questions about the Cambridge site. “Otherwise, you do trials that lead to nothing, and it’s a…
Britain’s biggest drugmaker says UK’s NHS pricing offer is still not enough – POLITICO
